ANTIPSYCHOTICS - RISPERIDONE

This tender concerns the procurement of antipsychotic medication, specifically Risperidone. The objective is to secure a supply of this prescription drug, which is used to treat various mental health conditions such as schizophrenia, bipolar disorder, and irritability associated with autism. The tender is likely issued by a healthcare provider, hospital, pharmacy, or public health authority responsible for patient medication. The scope includes the supply of Risperidone in various forms (e.g., tablets, oral solution, long-acting injection) and dosages as specified in the tender documents. Bidders are expected to be pharmaceutical manufacturers or authorized distributors possessing the necessary licenses and certifications to supply prescription medications. Evaluation criteria will primarily focus on the quality and authenticity of the drug, compliance with pharmaceutical regulations, pricing, and the reliability of the supply chain. Ensuring a consistent supply of essential medications like Risperidone is critical for the effective treatment and management of patients with serious mental health conditions.

This is a supplies contract in the health and medical services, Monitoring Evaluation and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 182,339.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.